Our data clearly show that CK18 is continuously expressed in different epithelial cancers, Specifically adenocarcinomas. the two lack of CK18 expression in cancers derived from CK18 constructive precursor cells and neo-expression in malignancies derived from CK18 constructive precursors are typically linked to unfavorable tumor phenotype and condit